A team of Vanderbilt researchers has developed a wirelessly activated device that mimics the wavelike muscular function in the esophagus and small intestine responsible for transporting food and viscous fluids for digestion.
Novartis reportedly in talks to buy MorphoSys; Astellas cuts PhII program; Silence’s $120M private placement
Plus, news about Adverum, BridgeBio Pharma, Vaxcyte, Corbus and Immunocore: Novartis reportedly in deal talks with MorphoSys: The Swiss Big Pharma is in advanced talks